Mustang Bio: Leading Cell Therapy Services with Miltenyi Solutions

We are excited to announce a collaborative effort between Mustang Bio and T&L Biotechnology Co., Ltd. to bring a revolutionary new product to the market. Our teams have been working tirelessly to develop a cutting-edge therapy that has the potential to transform the treatment of various diseases, Through this collaboration, we are introducing a groundbreaking biotechnology product that combines the expertise and resources of Mustang Bio and T&L Biotechnology Co., Ltd. This product represents a significant advancement in the field of oncology, with the potential to improve patient outcomes and quality of life, Our joint efforts have resulted in the creation of a novel therapy that targets specific genetic markers, offering a more precise and personalized treatment approach. This product has undergone rigorous testing and has shown promising results in preclinical studies, making it a promising candidate for further development and commercialization, We are committed to advancing this innovative product through the regulatory and clinical pathways to ultimately bring it to patients in need. Stay tuned for more updates on this exciting collaboration between Mustang Bio and T&L Biotechnology Co., Ltd. as we work towards bringing this transformative therapy to the market